Laurus Labs Announces Rs 64 Crore Acquisitions to Boost Peptide, Oligonucleotide Manufacturing
New Delhi: Contract Development and Manufacturing Organization (CDMO) Laurus Labs has announced two strategic acquisitions to strengthen its oligonucleotide and peptide…
TR
By Tom Reyes · Markets Editor
Nov 2 07:56 ETSource: Medical Dialogues
From the source
Read at medicaldialogues.inLaurus Labs Announces Rs 64 Crore Acquisitions to Boost Peptide, Oligonucleotide Manufacturing
New Delhi: Contract Development and Manufacturing Organization (CDMO) Laurus Labs has announced two strategic acquisitions to strengthen its oligonucleotide and peptide manufacturing capabilities, entering into a definitive agreement to acquire a 60 per cent stake in Canada-based Galenvs Science for USD 3.75 million and a 52 per cent stake in Hyderabad-based SI&C Resins for Rs 32 crore in cash.
